
The health tech start-up TaraCares has been awarded the highly competitive Fast Start Award by UKRI Innovate UK to progress research and innovation activities to develop an evidence-led, decentralised precision medicine platform tackling misinformation, misdiagnosis and mismanagement of menopause.
Thanks to Innovate UK, UK’s innovation agency which recognised the criticality of women’s health equity, TaraCares has been able to team up with a carefully selected set of experienced scientists, researchers, engineers, technologists, nutritionists and entrepreneurs who value science and robust research to inform women’s health.
The company works with women who participate on a volunteer basis to share their lived experience of menopause to help other women.
Research partnerships with leading universities is central to its execution strategy, as academia represents an important sector that needs to step up its efforts for mobilising support for staff in menopause transition.
The team behind TaraCares are proud to be collaborating with one such organisation that has stepped up – Sheffield Hallam University with Dr Sally Jackson, chief people officer and pro vice-chancellor (diversity and inclusion) at Hallam.

Funding from Innovate UK has propelled the company’s research into exploring Artificial Intelligence (AI) and machine learning capabilities for its digital health solutions, establishing AI in healthcare research collaboration with the University of Huddersfield.
Reflecting on the partnership, Dr Tianhua Chen, PhD senior lecturer in AI at the School of Computer Science and Engineering, University of Huddersfield, said: “It’s been very pleasant working with Jyoti [TaraCares founder] who I see is a very passionate, determined and Jill-of-all-trades entrepreneur striving to use clinical excellence and cutting-edge AI technologies to promote the understanding of menopause, which is an unmet global need in its awareness, diagnosis and management.”

TaraCares is committed to every single female across the globe to deliver precision medicine for menopause care irrespective of your socio-economic background, health status and type of menopause transition – natural, early, surgical, premature ovarian insufficiency (POI).
The team are breaking new ground and pioneering research in questions that have never been asked because society and governments have not been intentional about female health.
The start-up aims to spearhead a new paradigm of equitable female health where menopause and associated secondary health conditions, cardiovascular disorders, osteoporosis, anxiety and depression among others receive the individualised care that is warranted for long term female health.
If you are a female reading this, you can participate in TaraCares’ ongoing research.
By participating in the study you will be part of a global movement for delivering evidence-based, individualised and integrated menopause care that is accessible and affordable.

To learn more, visit taracares.co.uk or email [email protected].

Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.









